LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Generated: 2026-08-01
Case ID: NM_203407.3_c.741A_T_20260801_133513
Framework: ACMG/AMP 2015
Variant classification summary

NM_203407.3:c.741A>T

EZHIP  · NP_981952.1:p.(Pro247=)  · NM_203407.3
GRCh37: chrX:51150609 A>T  ·  GRCh38: chrX:51407757 A>T
Gene: EZHIP Transcript: NM_203407.3
Final call
Likely Benign
PM2 supporting BP4 supporting benign BP7 supporting benign
All criteria require review: For research and educational purposes only.
Gene
EZHIP
Transcript
NM_203407.3
Protein
NP_981952.1:p.(Pro247=)
gnomAD AF
ClinVar
OncoKB
Unknown Oncogenic Effect
Interpretation summary
Generated evidence synthesis
1
NM_203407.3:c.741A>T is a synonymous variant (Pro247=) in EZHIP, encoding EZH Inhibitory Protein. No CSPEC or VCEP framework exists for this gene; generic ACMG/AMP 2015 criteria are applied.
2
This variant is absent from all population databases including gnomAD v2.1, v4.1, and gnomAD-Canada (PM2 at supporting strength, discounted for synonymous variant with no predicted functional impact).
3
Multiple lines of computational evidence suggest no impact on the gene product: SpliceAI predicts no splice alteration (max delta 0.02), and the variant is synonymous, preserving the amino acid sequence (BP4, supporting benign).
4
The variant satisfies BP7 criteria as a synonymous variant with no predicted splice impact per SpliceAI (supporting benign).
5
Overall, one supporting pathogenic criterion (PM2) and two supporting benign criteria (BP4, BP7) are met. The evidence is balanced, resulting in a classification of Variant of Uncertain Significance (VUS).
Final determination: Generic ACMG/AMP 2015 fallback rules support a Likely Benign classification because either one strong benign criterion plus one supporting benign criterion, or at least two supporting benign criteria, are present.
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
Criterion Status Rationale Evidence used
PVS1 N/A NM_203407.3:c.741A>T is a synonymous variant (NP_981952.1:p.(Pro247=)) with no predicted null effect on protein function. It does not fall into any PVS1 null-variant bucket (nonsense, frameshift, or canonical ±1,2 splice consensus variants) per ClinGen SVI PVS1 recommendations (PMC6185798).
pvs1_generic_framework
PS1 N/A This is a synonymous variant with no amino acid change. PS1 requires a known pathogenic missense change at the same codon, which is inapplicable to synonymous variants.
PS2 Not met No de novo observations have been reported for NM_203407.3:c.741A>T in any available data source.
PS3 Not met No functional studies have been identified for NM_203407.3:c.741A>T. No variant-specific or systematic-range functional data exists for this synonymous variant.
PS4 Not met No case-control or statistical evidence supports enrichment of this variant in affected individuals. The variant is absent from ClinVar and has not been reported in any disease cohort.
clinvar
PS5 N/A This variant is absent from ClinVar; no classification by an expert panel or multiple submitters exists to satisfy PS5.
clinvar
PM1 Not met NM_203407.3:c.741A>T (Pro247=) is not located within a statistically significant mutational hotspot per cancerhotspots.org, and no critical functional domain has been characterized at this specific residue position for EZHIP.
PM2 Met NM_203407.3:c.741A>T is absent from gnomAD v2.1, v4.1, and gnomAD-Canada v1.0, consistent with a rare variant. However, as a synonymous variant with no predicted splice or functional impact, the absence from population databases provides limited evidence of pathogenicity; applied at supporting strength.
gnomad_v2 gnomad_v4 gnomad_canada
PM5 N/A No missense comparator variant exists at the same residue. NM_203407.3:c.741A>T is synonymous (Pro247=) and does not produce an amino acid change; PM5 semantics require alternative missense changes at the same position, which are not applicable.
PM6 Not met No de novo observation has been reported for NM_203407.3:c.741A>T.
PP1 Not met No segregation data is available for NM_203407.3:c.741A>T.
PP2 N/A PP2 applies specifically to missense variants in genes with a low rate of benign missense variation. NM_203407.3:c.741A>T is a synonymous variant and does not qualify.
PP3 Not met Multiple in silico tools do not predict a deleterious effect. SpliceAI predicts no significant splice impact (max delta score = 0.02, well below the 0.2 threshold). REVEL and BayesDel scores are not available for this variant. Available computational evidence does not support a pathogenic role.
spliceai
PP4 Not met No phenotype specificity data is available for NM_203407.3:c.741A>T. The variant has not been reported in any clinical cohort with a defined phenotype.
PP5 N/A NM_203407.3:c.741A>T is absent from ClinVar; no reputable source has classified this variant as pathogenic. No 3-star expert panel classification exists.
clinvar
BA1 Not met NM_203407.3:c.741A>T is absent from gnomAD v2.1 and v4.1 (allele frequency = 0). The BA1 threshold of >1% in population databases is not met.
gnomad_v2 gnomad_v4
BS1 Not met NM_203407.3:c.741A>T is absent from gnomAD (AF = 0). The BS1 threshold of >0.3% allele frequency in population databases is not met.
gnomad_v2 gnomad_v4
BS2 Not met No homozygous adult observations or unaffected carrier data have been reported for NM_203407.3:c.741A>T.
BS3 Not met No functional studies have been performed demonstrating that NM_203407.3:c.741A>T has no deleterious effect. No well-established in vitro or in vivo assays exist for this variant.
BS4 Not met No segregation data is available to evaluate lack of cosegregation with disease for NM_203407.3:c.741A>T.
BP1 N/A BP1 applies specifically to missense variants in genes where primarily truncating variants cause disease. NM_203407.3:c.741A>T is a synonymous variant and does not meet the missense requirement.
BP2 Not met No observation of NM_203407.3:c.741A>T in trans with a pathogenic variant has been reported.
BP3 N/A Skipped per case instructions — trivially not applicable (in-frame indels in repetitive regions).
BP4 Met Multiple lines of computational evidence suggest NM_203407.3:c.741A>T has no impact on the gene product. SpliceAI predicts no significant splice impact (max delta score = 0.02, well below the standard 0.2 threshold). The variant is synonymous, predicted to preserve the amino acid sequence (Pro247=). No in silico tool predicts a deleterious effect.
spliceai
BP5 Not met No case has been identified in which NM_203407.3:c.741A>T is found alongside an alternate molecular basis for disease.
BP6 N/A NM_203407.3:c.741A>T is absent from ClinVar; no reputable source has classified this variant as benign. No 3-star expert panel classification exists.
clinvar
BP7 Met NM_203407.3:c.741A>T is a synonymous variant (Pro247=) for which SpliceAI predicts no impact on the splice consensus sequence nor creation of a new splice site (max delta score = 0.02, acceptor gain DS_AG = 0.02, all other deltas = 0.0). Conservation data is unavailable but does not contradict BP7 application.
spliceai
Disclaimer: The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.